coronavirus

The May 2020 issue of Research!America's newsletter, The Research Advocate, is now online! In this issue: Research!America's Response to COVID-19 : In January 2020, the first case of COVID-19 was reported in Washington state. The days since then have been unprecedented in global history. The medical and research community, including so many of our alliance members, have taken on the incredible challenge of beating back the novel coronavirus, not just on the front lines in hospitals, but in laboratories across the world working to understand the virus to protect public health. Webinar Explores COVID-19 Vaccines and Treatment : As the COVID-19 pandemic surpasses one million cases in the...
Since the outbreak of the novel coronavirus, the ability to diagnose and test for the presence of the virus in patients has been of critical importance. However, the process and steps required in testing have not always been made clear or easy for non-experts to understand. Research!America has developed this resource to explain the scientific process behind a COVID-19 test. During a recent Research!America alliance member call, Scott Whitaker, President and CEO of AdvaMed discussed how diagnostic companies are developing and manufacturing both “front end” tests to detect whether a person currently has COVID-19 and serology tests to determine whether someone has ever had COVID-19 by...
Dear Research Advocate, Jumping right in: Funding, Current and Future : Democratic Leaders in the House are focusing on the Moving Forward Framework , an infrastructure investment blueprint they originally released in January 2020, as the foundation for a fourth, $2 trillion supplemental. As it stands, both House Republicans and the Senate seem reluctant to pass another supplemental; nonetheless, the prospects for an infrastructure-focused stimulus are strong. We have heard that Congress and the administration may opt to roll FY21 funding into the aforementioned infrastructure supplemental rather than go the well-worn (and progress-stifling) “Continuing Resolution” route. While at this...
Dear Research Advocate, Congress is expected to pass a stimulus bill that includes significant investments in our nation’s key research agencies. The Coronavirus Aid, Relief and Economic Security (CARES) Act includes $27 billion to BARDA for critical medical supplies, personal protective equipment (PPE), and the manufacturing and purchase of vaccines and therapeutics; $4.3 billion to CDC for public health preparedness and response; $945 million to NIH for vaccine, therapeutic, and diagnostic research; $80 million to FDA for additional funding for vaccines, medical product manufacturing, and medical supply chain monitoring; and $75 million to NSF for research and grant programs related to...
The Research!America team is working remotely as are many of you to take precautions against COVID-19. But we are certainly not slowing down. We are working hard to assure federal funding and policy actions are evidence-based and match the urgency needed to: Support the flexibility and funding research institutions need during this challenge. Capture and reflect back the essential role public and private sector fueled science is playing in addressing COVID-19. Promote completion of the FY21 appropriations process, critical to economic stability and strategic capacity going forward. We will continue to keep you updated about important advocacy opportunities and other valuable COVID-19-...
Dear Research Advocate, At this challenging time, Research!America is laser-focused on helping to advance policy and funding actions to speed the day we see the end of the COVID-19 pandemic. You will be hearing more from us as we share what we know, including ways you can get involved in advocacy at this important time. We invite you to be in touch with us with your suggestions. While we took the step of postponing one of our signature events — our Advocacy Awards Dinner — we look forward to announcing a new date. As we hit the “send” button, members of Congress and the White House are negotiating a supplemental budget package focused on mitigating the economic impact of the COVID-19...
Dear Research Advocate, In their different ways, Super Tuesday and COVID-19 both speak to public sentiment. What are Americans’ expectations for those who represent them in Washington — and candidates who want to represent them in Washington — when it comes to promoting and protecting their best interests? A new Research!America-commissioned survey (in the field just days before COVID-19 captured worldwide public attention) found that Americans want their policymakers to consult with public health professionals and scientists; are deeply concerned about a diversity of public health issues affecting their families, their communities, and our nation as a whole; and believe there should be...
Dear Research Advocate, Super Tuesday is just days away. While media is largely focused on the Presidential candidates, candidates for Congress will also be selected. As we head into the general election, Research!America will be launching a non-partisan initiative to inform all candidates about where voters stand on medical and scientific research. Earlier this month, we released data from our January survey demonstrating widespread, bipartisan support for more research funding to address the many critical health issues facing Americans today. More poll data from our January survey will be online shortly; watch for it, and put it to use! We all think it’s important that candidates know...
Dear Research Advocate, The President released his proposed budget for FY21 earlier this week, kicking off the federal budget season. The President’s budget is a statement of priorities, even if it has no force of law (it’s the Congress that is charged in the Constitution with the ‘power of the purse’), and it rightly gets considerable attention. We think it’s deeply damaging for our nation that a higher priority isn’t being placed on science. Among the counterproductive proposals in the budget is a more than 7% cut to NIH and a double-digit cut to the CDC. Our colleague Jenny was quoted in Bloomberg Government as noting that, as underscored by the coronavirus outbreak, “the most important...
Dear Research Advocate, We were pleased to hear President Trump, in his State of the Union address (SOTU) earlier this week, highlight the importance of progress against health threats. Specifically he referenced mental health challenges, Alzheimer’s disease, kidney disease, HIV/AIDS, the opioid epidemic, childhood cancer, and the current coronavirus outbreak. What we didn’t hear, unfortunately, is that the President will grow federal funding for research. Nor did we hear him speak of plans to assure U.S. leadership in the global R&D arena, giving it the priority merited by its strategic significance. The President’s references during the SOTU to dramatically lowering prescription drug...

Pages

Sidebar Quote

America’s economic destiny lies in innovation, technology, science and research.
The Honorable John E. Porter